Wuhan Hiteck Biological Pharma Co (SZSE:300683) FCF Yield % : -3.38 (As of Jun. 22, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Wuhan Hiteck Biological Pharma Co's Trailing 12-Month Free Cash Flow is ¥-98.6 Mil, and Market Cap is ¥2,918.9 Mil. Therefore, Wuhan Hiteck Biological Pharma Co's FCF Yield % for today is -3.38%.

The historical rank and industry rank for Wuhan Hiteck Biological Pharma Co's FCF Yield % or its related term are showing as below:

SZSE:300683' s FCF Yield % Range Over the Past 10 Years
Min: -6.11 Med: -1.37 Max: 3.25
Current: -3.38

During the past 11 years, the highest FCF Yield % of Wuhan Hiteck Biological Pharma Co was 3.25%. The lowest was -6.11%. And the median was -1.37%.

SZSE:300683's FCF Yield % is ranked worse than
63.43% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.16 vs SZSE:300683: -3.38

Wuhan Hiteck Biological Pharma Co's FCF Margin % for the quarter that ended in Mar. 2024 was -5.86%.

Wuhan Hiteck Biological Pharma Co FCF Yield % Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co FCF Yield % Chart

Wuhan Hiteck Biological Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-1.71

-3.16

-3.23

-2.80

-3.43

Wuhan Hiteck Biological Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-5.90	-1.30	-4.30	-1.75	-0.91

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Hiteck Biological Pharma Co's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's FCF Yield % falls into.

Wuhan Hiteck Biological Pharma Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Wuhan Hiteck Biological Pharma Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-162.127	/	4726.58234
	=	-3.43%

Wuhan Hiteck Biological Pharma Co's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-7.725	*	4	/	3384.91884
	=	-0.91%

Wuhan Hiteck Biological Pharma Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Wuhan Hiteck Biological Pharma Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » FCF Yield %

Traded in Other Exchanges

N/A

Address

Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056

Website

http://www.hiteck.com.cn

Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Executives

Yan Jie	Director
Li Sheng Qiang	Executives

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines

No Headlines